Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Aug 18;18(1):383.
doi: 10.1186/s13063-017-2128-8.

Impact of early initiation versus national standard of care of antiretroviral therapy in Swaziland's public sector health system: study protocol for a stepped-wedge randomized trial

Fiona J Walsh  1 , Till Bärnighausen  2   3   4 , Wim Delva  5   6   7   8 , Yvette Fleming  9 , Gavin Khumalo  10 , Charlotte L Lejeune  11 , Sikhathele Mazibuko  12 , Charmaine Khudzie Mlambo  11 , Ria Reis  13   14   15 , Donna Spiegelman  2 , Mandisa Zwane  16 , Velephi Okello  12
Affiliations
Randomized Controlled Trial

Impact of early initiation versus national standard of care of antiretroviral therapy in Swaziland's public sector health system: study protocol for a stepped-wedge randomized trial

Fiona J Walsh et al. Trials. .

Abstract

Background: There is robust clinical evidence to support offering early access to antiretroviral treatment (ART) to all HIV-positive individuals, irrespective of disease stage, to both improve patient health outcomes and reduce HIV incidence. However, as the global treatment guidelines shift to meet this evidence, it is still largely unknown if early access to ART for all (also referred to as "treatment as prevention" or "universal test and treat") is a feasible intervention in the resource-limited countries where this approach could have the biggest impact on the course of the HIV epidemics. The MaxART Early Access to ART for All (EAAA) implementation study was designed to determine the feasibility, acceptability, clinical outcomes, affordability, and scalability of offering early antiretroviral treatment to all HIV-positive individuals in Swaziland's public sector health system.

Methods: This is a three-year stepped-wedge randomized design with open enrollment for all adults aged 18 years and older across 14 government-managed health facilities in Swaziland's Hhohho Region. Primary endpoints are retention and viral suppression. Secondary endpoints include ART initiation, adherence, drug resistance, tuberculosis, HIV disease progression, patient satisfaction, and cost per patient per year. Sites are grouped to transition two at a time from the control (standard of care) to intervention (EAAA) stage at each four-month step. This design will result in approximately one half of the total observation time to accrue in the intervention arm and the other half in the control arm. Our estimated enrolment number, which is supported by conservative power calculations, is 4501 patients over the course of the 36-month study period. A multidisciplinary, mixed-methods approach will be adopted to supplement the randomized controlled trial and meet the study aims. Additional study components include implementation science, social science, economic evaluation, and predictive HIV incidence modeling.

Discussion: A stepped-wedge randomized design is a causally strong and robust approach to determine if providing antiretroviral treatment for all HIV-positive individuals is a feasible intervention in a resource-limited, public sector health system. We expect our study results to contribute to health policy decisions related to the HIV response in Swaziland and other countries in sub-Saharan Africa.

Trial registration: ClinicalTrials.gov, NCT02909218 . Registered on 10 July 2016.

Keywords: Antiretroviral treatment; HIV/AIDS; Prevention; Swaziland.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The trial was approved by the Swaziland National Health Research Review Board in July 2014 (Reference Number: MH/599C/FWA 000 15267). All participants must be able and willing to give verbal consent for trial participation. The final report will follow the CONSORT reporting guidelines for cluster trials [26] and the recommendations for reporting stepped-wedge trials proposed by Hemming et al. [27].

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Map of study sites in Hhohho Region
Fig. 2
Fig. 2
Stepped-wedge study design
Fig. 3
Fig. 3
Trial flow diagram
See this image and copyright information in PMC

References

    1. UNAIDS . Report on the Global HIV/AIDS Epidemic. Geneva: UNAIDS; 2000.
    1. UNAIDS . Global AIDS Update. Geneva: UNAIDS; 2016.
    1. UNAIDS. Fast-track update on investments needed in the AIDS response (2016). Geneva: UNAIDS. http://www.unaids.org/en/resources/documents/2016/unaids_fast-track_upda.... Accessed 1 Apr 2016.
    1. Government of South Africa. Minister Aaron Motsoaledi: Health Department Budget Vote 2016/2017. 2016. http://www.gov.za/speeches/debate-health-budget-vote-national-assembly-1.... Accessed 17 July 2016.
    1. Atun R, Chang AY, Ogbuoji O, Silva S, Resch S, Hontelez J, et al. Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study. BMJ Open. 2016;6:e009656. doi: 10.1136/bmjopen-2015-009656. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Associated data